Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

Nov 1, 2006
300 Pages - Pub ID: KLI1362425
Attention: There is an updated edition available for this report.
Abstract Table of Contents Search Inside Report Buy By the Section Related Reports

Chapter One: Executive Summary
  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

Chapter Two: Introduction

  • Background
  • Miniaturization, digitization and informatics
  • The pros and cons of POC testing
  • Point of View

Chapter Three: Market and Technological Dynamics

  • Background
  • The emergence of non-invasive technologies
  • Pharmacogenomics (PGx) on Demand
  • Lab-on-a-Chip
  • The Wireless Revolution
  • Connectivity Imperative
  • Non-Invasive Sampling
  • Regulatory environment

Chapter Four: The Economics of POC Testing: Revenue Opportunity

  • Background
  • POC and Clinical Outcomes Management
  • POC and Organization Culture Change
  • POC in the Management of Critical Care Patients
  • Reimbursement Trends
  • Migration of POC to the Core Lab: The Lab Fights Back
  • More than Device Installation: Training and QC

Chapter Five: Market Analysis

  • Market Overview
  • POC in World Markets
  • The Major Players
  • Over-the-Counter (OTC) Tests
  • Physician Office Labs (POLs) and Clinic Testing for Early Disease Detection
  • POC Testing in the Hospital
  • Home Monitoring of Individuals with Chronic Diseases
  • POC Test Segments
    • Blood Glucose
    • Cardiac markers
    • Clinical Chemistry/Hematology
    • Coagulation
    • Critical care analytes - Blood Gas/Electrolytes
    • Drugs of Abuse
    • Infectious Diseases
    • Pharmacogenetics
    • Pregnancy/Fertility
    • Sepsis
    • Oncology
    • Women’s health
    • Urinalysis

  • Emerging Tests and Technologies
  • Commercial Outlook

Chapter Six: Company Briefs

  • The Top IVD Companies and Their POC Offerings
    • Abbott Laboratories
    • Bayer Corporation / Siemens
    • Beckman-Coulter Diagnostics
    • bioMerieux Inc.
    • Dade Behring Inc.
    • Daiichi Pure Chemicals Co., Ltd.
    • Instrumentation Laboratory (IL)
    • Roche Diagnostics

  • POC Companies and New Frontiers
    • Abaxis Inc.
    • Abbott Diagnostics
    • Accumetrics, Inc.
    • Accurex Biomedical, Pvt., Ltd
    • Actimed Diagnostics
    • Adeza Biomedical Corporation
    • Aerscher Diagnostics
    • Akers Bioscience
    • Ambri Ltd
    • American Bio Medica Corp.
    • American Biogenetic Sciences, Inc
    • Ani Biotech
    • Ark Therapeutics
    • Array Medical
    • Avitar, Inc.
    • Avox Systems
    • Axis-Shield
    • Bayer Corporation
    • Beacon Diagnostics
    • Biex Inc.
    • Binax Corporation
    • Biomerica
    • BioMérieux Vitek, Inc.
    • BioScan Screening Systems, Inc.
    • Biosite Diagnostics
    • Biostar
    • Caliper Technologies
    • Calypte Biomedical
    • Cardiovascular Diagnostics (Pharmanetics)
    • Cholestech
    • Chongqing Sungene Pharmaceutical Co., Ltd
    • Compucyte Corporation
    • Cortech Ltd.
    • Cozart Biosciences
    • Cygnus Therapeutic Systems
    • Cytogen
    • Dade Behring
    • Denka Seiken Co., Ltd.
    • Diagnology, Inc.
    • Diametrics Medical, Inc.
    • Disetronic Medical Systems
    • Dynagen
    • Ely Labs
    • Enterix, Inc.
    • GDS Technology GenBio
    • Genzyme Diagnostics
    • Gryphus Diagnostics
    • Helena Laboratories
    • Hemocue, Inc.
    • Home Access Health Corp
    • Iatron
    • Immunoscience, Inc.
    • Instrumentation Laboratory
    • International Medical Innovations
    • Inverness
    • i-Stat Corporation
    • Jiangnan Biotech
    • Johnson & Johnson
    • Kyowa Medex Co., Ltd.
    • LifeAssays
    • LifePoint, Inc.
    • LifeScan Corporation
    • Lifestream Technologies 266
    • LXN Corp (Inverness Medical Technologies)
    • Matritech
    • Medical Services International Inc.
    • Medisense
    • Medix Biochemica
    • MedMira Laboratories
    • Medtronic Cardiac Surgery (ACT)
    • Medtronic
    • Meretek Corporation
    • Meridian Diagnostic
    • Micro Diagnostics Corp
    • MiniMed
    • New Horizons Diagnostics
    • Nova Biomedical
    • Optical Sensors Inc.
    • Orasure
    • Orgenics
    • Orion Diagnostica
    • PanBio Corp
    • Pharmanetics, Inc.
    • Pharmatech Corporation
    • Point of Care Technologies
    • Polymedco
    • Polymer Technology Systems
    • PreMD
    • Princeton BioMeditech Corporation
    • Quidel
    • Radiometer
    • Rapid Bio Tests Corporation
    • Response Biomedical Corp.
    • Roche Diagnostics
    • Royal Philips Electronics
    • Phillips Medical Systems
    • Saliva Diagnostics
    • Savyon Diagnostics
    • Selfcare, Inc.
    • Seradyn Clinical Diagnostics/Apogent Technologies
    • Shanghai Siic Kehua Biotech Co., Ltd. (Kehua Biotech)
    • Sienco
    • Simplex Medical Systems
    • SmithKline/Beckman Diagnostics
    • Spectral Diagnostics
    • SpectRx, Inc.
    • Stat Site Meter
    • STC Technologies
    • Sun Biomedical Laboratories
    • Sybron International Corporation
    • Taiwan Diagnostic
    • Therasense, Inc.
    • Thoratec/International Technidyne Corp
    • Transmedica
    • Trinity Biotech
    • Wampole Laboratories
    • Worldwide Medical Corporation
    • Wyntek Diagnostics

List of Exhibits

  • Exhibit 1: Market Summary: Worldwide POC Sales 2005-2010
  • Exhibit 2: Selected New Biochip Products (Company, Product, Target)
  • Exhibit 3: U.S. Lab Reimbursement by Recipient (Quest, LabCorp, Other Reference Lab, Hospital Lab, Physician Office Lab), 2005
  • Exhibit 4: World POC OTC Sales by Test Category (Glucose, Pregnancy/Ovulation, Coagulation/PT, Fecal Occult Blood, Drugs Of Abuse, H. Pylori, HIV, Cholesterol, Other) 2005-2010
  • Exhibit 5 World POC Professional Sales by Test Category (Glucose, Critical Care, Pregnancy, Infectious Diseases, Cardiac Markers, Cholesterol/Lipids, Coagulation/PT/ACT, HbA1c, Hemoglobin, Fecal Occult Blood, Drugs of Abuse, Bilirubin, Other) 2005-2010
  • Exhibit 6: POC Test Revenues of Selected IVD Companies (Top 40 Competitors), 2005
  • Exhibit 7: Selected Direct-to-Consumer Tests on the Market
  • Exhibit 8: Selected OTC Test Devices on the Market (Company, Device, Target)
  • Exhibit 9: Selected Professional POC Tests on the Market and in Development (Company, Device, Target, Development Status)
  • Exhibit 10: World Glucose Monitoring Sales and Market Share by Company and Segment (Professional vs OTC), 2005
  • Exhibit 11: Selected Blood Glucose Test Devices on the Market (Company, Product, Development Status)
  • Exhibit 12: HgbA1c Test Market by Setting (Lab vs POC) and Region (United States, Europe, ROW), Revenues, Average Cost per Test, Number of Tests 2005
  • Exhibit 13: Worldwide Sales of Selected Lab Based Cardiac IVDs (Cholesterol/Lipid Markers, CRP/Inflammation Markers, AMI Enzymes, BNP, Homocysteine, D-Dimer), 2005-2010
  • Exhibit 14: Worldwide Sales of Selected Professional POC Cardiac IVDs (Cholesterol/Lipid Markers, AMI Enzymes, BNP, D-Dimer), 2005-2010
  • Exhibit 15: Worldwide Sales of OTC Cholesterol/Lipid Tests, 2005-2010
  • Exhibit 16: Cardiac IVD Testing Volumes by Region (United States, Europe, ROW) and Test (6 Lab-Based Tests, 4 Professional POC Tests, OTC Cholesterol [see Exhibits 13, 14, and 15 for specific tests]), 2005
  • Exhibit 17: PT Testing Volume by Region (United States, Europe, ROW) and Type (Lab, Professional POC, OTC), 2005
  • Exhibit 18: Infectious Disease Testing Volumes by Region (United States, Europe, ROW) and Test (Strep A, Influenza, HIV, Vaginitis, Chlamydia, H. pylori, Meningitis, Mononucleosis, Strep B, Strep. Pneum, Others), 2005
  • Exhibit 19: Selected SNP-Drug Interactions
  • Exhibit 20: Fecal Occult Blood (FOB) Testing Volumes by Region (United States, Europe, ROW) and Type (POC Professional Guaiac, POC Professional Immunochemical, OTC Guaiac/immuno, OTC Flushable), 2005
  • Exhibit 21: Women’s Health Testing Volumes by Region (United States, Europe, ROW) and Type (Professional Pregnancy, OTC Pregnancy, OTC LH/Ovulation), 2005
  • Exhibit 22: Selected OTC Non-Pregnancy Women’s Health and Fertility Tests on the Market

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 6th Edition [with 2009 economy preface]
The World Market for Molecular Diagnostics
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies
2009 Worldwide Diagnostics Market Research Bundle
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2010 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Trust-e Logo
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 3:00am - 7:00pm EST
Fridays: 3:00am - 6:00pm EST